Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05366699 · ClinicalTrials.gov registry record · NA
LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy
A NA study of Lymphedema and Lymphedema, Breast Cancer, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05366699 is a NA study of Lymphedema and Lymphedema, Breast Cancer that is actively recruiting participants, run by Stanford University. The registered enrollment target is 80 participants, below the 9,297-participant average among 34 other Lymphedema trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05366699, a NA study of Lymphedema and Lymphedema, Breast Cancer, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
Lymphedema is a chronic, progressive, and debilitating condition that occurs with disruption or obstruction of the lymphatic system, which commonly occurs a result of breast cancer therapy. The purpose of this study is to determine if the use of a low risk lymphatic reconstruction procedure at the time of axillary lymph node dissection will reduce the risk of developing lymphedema. Additionally, to determine if this procedure improves objective outcomes of lymphedema and patient quality of life
Conditions Studied
Interventions
- PROCEDURE axillary lymphadenectomy with immediate lymphatic reconstruction (LYMPHA)
- PROCEDURE Axillary lymphadenetomy alone
- PROCEDURE axillary lymphadenectomy with soft tissue reinforcement
Study Locations (1)
California
- Stanford Cancer Institute - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-09-10 |
| Est. Completion | 2030-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05366699
The ClinicalTrials.gov registry entry for NCT05366699 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,297-participant average among 34 other Lymphedema trials with a reported enrollment target (99% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Lymphedema appearing as the primary indexed condition, and to 3 interventions - of which axillary lymphadenectomy with immediate lymphatic reconstruction (LYMPHA) is the first listed.
NCT05366699 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05366699 about?
NCT05366699 is a clinical study titled "LYMPHA Procedure for the Prevention of Lymphedema After Axillary Lymphadenectomy". Lymphedema is a chronic, progressive, and debilitating condition that occurs with disruption or obstruction of the lymphatic system, which commonly occurs a result of breast cancer therapy. The purpose of this study is to determine if the use of a low risk lymphatic reconstruction procedure at the t...
What is the current status of trial NCT05366699?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2021-09-10. Estimated completion is 2030-06-01.
What conditions does trial NCT05366699 study?
This clinical trial studies the following conditions: Lymphedema, Lymphedema, Breast Cancer.
What interventions are being tested in trial NCT05366699?
The interventions under investigation include: axillary lymphadenectomy with immediate lymphatic reconstruction (LYMPHA) (PROCEDURE), Axillary lymphadenetomy alone (PROCEDURE), axillary lymphadenectomy with soft tissue reinforcement (PROCEDURE).
Who is sponsoring clinical trial NCT05366699?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05366699 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphedema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)
RECRUITING · NA
-
Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema
RECRUITING · NA
-
A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic Surgery
RECRUITING · NA
-
Pedal Pump and Leg Lymphedema
RECRUITING · NA
-
Comparing Two Ways to Manage Head and Neck Lymphedema
RECRUITING · NA
-
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.